Corporate information
Official name
Raven Biotechnologies Incorporated
Registration country
Company type
A biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer.Funding rounds
Acquisition
( )
Investor | Profile | Country | |
---|---|---|---|
MacroGenics Inc | Biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases. |
Series D
( )
Investor | Profile | Country | Notes | |
---|---|---|---|---|
The Bank of Tokyo - Mitsubishi UFJ Capital Co Ltd | Initial investment. |
Series D
( )
Investor | Profile | Country | |
---|---|---|---|
US Venture Partners. (USVP) | Silicon Valley venture capital firm. |
Investor | Profile | Country | |
---|---|---|---|
Western Technology Investment (WTI) | Venture debt firm investing debt and equity capital in venture-backed technology, healthcare and clean technology companies. |
Investor | Profile | Country | |
---|---|---|---|
CMEA Capital (CMEA Ventures), (Chemical and Materials Enterprise Associates) |
Investor | Profile | Country | |
---|---|---|---|
EDB Investments Pte (EDBi) | The venture arm of Singapore's Economic Development Board. |
Investment activity status
Active investor